Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational oral therapy Haduvio™ (nalbuphine ER). Haduvio’s unique centrally and peripherally active mechanism of action (MOA) has the potential to rebalance the kappa and mu receptors which may play a significant role in chronic cough. Haduvio demonstrated a 75% reduction in daytime cough frequency for idiopathic pulmonary fibrosis (IPF) patients in its Phase 2 Cough And NALbuphine trial. With this positive data, Trevi is focusing future clinical development on chronic cough conditions, including IPF, interstitial lung diseases, and refractory chronic cough. Trevi is headquartered in New Haven, CT.
View Top Employees from Trevi Therapeutics, Inc.| Website | http://trevitherapeutics.com |
| Ticker | TRVI |
| Revenue | $3 million |
| Funding | $171.5 million |
| Employees | 28 (28 on RocketReach) |
| Founded | 2011 |
| Address | 195 Church Street 14th Floor, New Haven, Connecticut 06510, US |
| Phone | (203) 304-2499 |
| Technologies |
JavaScript,
HTML,
PHP
+21 more
(view full list)
|
| Industry | Biotechnology Research, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Healthcare, Health Care, Pharmaceutical |
| Web Rank | 6 Million |
| Keywords | Trevi Therapeutics, Trevi Therapeutics, Inc., Nalbuphine Er Tablets, Nalbuphine Hydrochloride Er, Nalbuphine |
| Competitors | Angiochem, GlycoMimetics, Mimetogen Pharmaceuticals Inc., Patrys Limited, Precision Biologics |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies |
Looking for a particular Trevi Therapeutics, Inc. employee's phone or email?
Trevi Therapeutics, Inc. Questions
The Trevi Therapeutics, Inc. annual revenue was $3 million in 2024.
Lisa Delfini is the CFO of Trevi Therapeutics, Inc..
28 people are employed at Trevi Therapeutics, Inc..
Trevi Therapeutics, Inc. is based in New Haven, Connecticut.
The NAICS codes for Trevi Therapeutics, Inc. are [32, 325, 3254, 32541].
The SIC codes for Trevi Therapeutics, Inc. are [28, 283].
Top Trevi Therapeutics, Inc. Employees
-
13
-
52
-
25+
-
ViewKatherine Takaki
Vice President, Global Regulatory Affairs at Trevi Therapeutics, Inc.
Middletown, CT, US23 -
43
-
25+
-
25+
-
ViewKevin Fitzmaurice
Senior Director, Technical Operations at Trevi Therapeutics, Inc.
Middlebury, CT, US45+ -
55+
Related Companies
